<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38618011</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-3546</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>Brain, behavior, &amp; immunity - health</Title><ISOAbbreviation>Brain Behav Immun Health</ISOAbbreviation></Journal><ArticleTitle>Reply to the letter to the editor "before attributing impaired cognition in the elderly to COVID-19, all influencing factors must be considered".</ArticleTitle><Pagination><StartPage>100740</StartPage><MedlinePgn>100740</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100740</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbih.2024.100740</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rizzi</LastName><ForeName>Greta</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Public Health, Faculty of Biomedical Sciences, Universit&#xe0; della Svizzera italiana, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albanese</LastName><ForeName>Emiliano</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute of Public Health, Faculty of Biomedical Sciences, Universit&#xe0; della Svizzera italiana, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Brain Behav Immun Health</MedlineTA><NlmUniqueID>101759062</NlmUniqueID><ISSNLinking>2666-3546</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cognitive COVID</Keyword><Keyword MajorTopicYN="N">Cognitive impairment</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">Serological assessment</Keyword></KeywordList><CoiStatement>There are no conflict of interest among authors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>15</Day><Hour>4</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38618011</ArticleId><ArticleId IdType="pmc">PMC11010793</ArticleId><ArticleId IdType="doi">10.1016/j.bbih.2024.100740</ArticleId><ArticleId IdType="pii">S2666-3546(24)00018-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Almeria M., Cejudo J.C., Sotoca J., Deus J., Krupinski J. Cognitive profile following COVID-19 infection: clinical predictors leading to neuropsychological impairment. Brain, Behavior, &amp; Immunity - Health. 2020;9 doi: 10.1016/j.bbih.2020.100163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2020.100163</ArticleId><ArticleId IdType="pmc">PMC7581383</ArticleId><ArticleId IdType="pubmed">33111132</ArticleId></ArticleIdList></Reference><Reference><Citation>Amati R., Piumatti G., Franscella G., Buttaroni P., Camerini A.-L., Corna L., Levati S., Fadda M., Fiordelli M., Annoni A.M., Bezani K., Amendola A., Fragoso Corti C., Sabatini S., Kaufmann M., Frei A., Puhan M.A., Crivelli L., Albanese E., on behalf of the Corona Immunitas Ticino Study Group Trajectories of seroprevalence and neutralizing activity of antibodies against SARS-CoV-2 in southern Switzerland between july 2020 and july 2021: an ongoing, prospective population-based cohort study. Int. J. Environ. Res. Publ. Health. 2023;20(4):3703. doi: 10.3390/ijerph20043703.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20043703</ArticleId><ArticleId IdType="pmc">PMC9964112</ArticleId><ArticleId IdType="pubmed">36834397</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P., Liu J., Liu M. Effect of COVID-19 vaccines on reducing the risk of Long covid in the real world: a systematic review and meta-analysis. Int. J. Environ. Res. Publ. Health. 2022;19(19) doi: 10.3390/ijerph191912422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912422</ArticleId><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths A.W., Smith S.J., Martin A., Meads D., Kelley R., Surr C.A. Exploring self-report and proxy-report quality-of-life measures for people living with dementia in care homes. Qual. Life Res. 2020;29(2):463&#x2013;472. doi: 10.1007/s11136-019-02333-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-019-02333-3</ArticleId><ArticleId IdType="pmc">PMC6994428</ArticleId><ArticleId IdType="pubmed">31646416</ArticleId></ArticleIdList></Reference><Reference><Citation>Hladek M.D., Zhu J., Buta B.J., Szanton S.L., Bandeen&#x2010;Roche K., Walston J.D., Xue Q. Self&#x2010;efficacy proxy predicts frailty incidence over time in non&#x2010;institutionalized older adults. J. Am. Geriatr. Soc. 2021;69(12):3507&#x2013;3518. doi: 10.1111/jgs.17417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.17417</ArticleId><ArticleId IdType="pmc">PMC8648965</ArticleId><ArticleId IdType="pubmed">34418062</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilic T., Weissleder R., Lee H. Molecular and immunological diagnostic tests of COVID-19: current status and challenges. iScience. 2020;23(8) doi: 10.1016/j.isci.2020.101406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101406</ArticleId><ArticleId IdType="pmc">PMC7381402</ArticleId><ArticleId IdType="pubmed">32771976</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales M., Barbar R., Gandhi D., Landuge S., Bae J., Vats A., Kothari J., Shankar S., Sukumaran R., Mathur H., Misra K., Saxena A., Patwa P., T V S., Arseni M., Advani S., Jakimowicz K., Anand S., Katiyar P., Raskar R. 2021. COVID-19 Tests Gone Rogue: Privacy, Efficacy,Mismanagement and Misunderstandings.</Citation></Reference><Reference><Citation>Sidiq Z., Hanif M., Dwivedi K.K., Chopra K.K. Benefits and limitations of serological assays in COVID-19 infection. Indian J. Tubercul. 2020;67(4):S163&#x2013;S166. doi: 10.1016/j.ijtb.2020.07.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijtb.2020.07.034</ArticleId><ArticleId IdType="pmc">PMC7409828</ArticleId><ArticleId IdType="pubmed">33308664</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>